CVS Health — Feb 12, 2025 release

to $372.8 billion, up 4.2% compared to prior year • GAAP diluted EPS of $3.66 and Adjusted EPS of $5.42 • Generated cash flow from operations of $9.1 billion 2025 Full-Year Guidance • GAAP diluted EPS guidance range of $4.58 to $4.83 • Adjusted EPS guidance range of $5.75 to $6.00 • Cash flow from operations guidance of approximately $6.5 billion CEO Commentary “Our integrated model allows us to uniquely deliver a simpler, connected experience that saves time, saves money, and improves health. We have continued to see growth in key areas of our business, including the Pharmacy and Consumer Wellness segment, while we address the industry-wide challenges that have impacted our Health Care Benefits segment. Through the continued dedication of our colleagues, we will be positioned for strong performance in 2025 as we deliver simply better care for consumers while improving outcomes and reducing costs.” — David Joyner, CVS Health President and CEO WOONSOCKET, RHODE ISLAND, February 12, 2025 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2024. Financial Results Summary Three Months Ended December 31, In millions, except per share amounts 2024 2023 Change Total revenues $ 97,710  $ 93,813  $ 3,897  Operating income 2,368  3,373  (1,005) Adjusted operating income (1) 2,728  4,227  (1,499) Diluted earnings per share $ 1.30  $ 1.58  $ (0.28) Adjust